These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11126390)

  • 21. [Pathological change of brain and premorbid vulnerability to stress in patients with schizophrenia].
    Suzuki M; Takahashi T; Uehara T; Zhou S; Kawasaki Y; Sumiyoshi T; Kuratomo M; Ozaki N
    Seishin Shinkeigaku Zasshi; 2007; 109(8):765-700. PubMed ID: 18050899
    [No Abstract]   [Full Text] [Related]  

  • 22. Schizophrenia and the disconnection hypothesis.
    Friston KJ
    Acta Psychiatr Scand Suppl; 1999; 395():68-79. PubMed ID: 10225335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
    Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH
    Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The cadherin hypothesis of schizophrenia].
    Gross J; Grimm O; Meyer J; Lesch KP
    Fortschr Neurol Psychiatr; 2003 Feb; 71(2):84-8. PubMed ID: 12579471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness].
    Schuld A; Hinze-Selch D; Pollmächer T
    Nervenarzt; 2004 Mar; 75(3):215-26. PubMed ID: 15021922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental neuropathology and the precursors of schizophrenia.
    Walker EF; Diforio D; Baum K
    Acta Psychiatr Scand Suppl; 1999; 395():12-9. PubMed ID: 10225328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain changes during the onset of schizophrenia: implications for neurodevelopmental theories.
    Wood SJ; Pantelis C; Yung AR; Velakoulis D; McGorry PD
    Med J Aust; 2009 Feb; 190(S4):S10-3. PubMed ID: 19220166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target.
    Calabrese F; Riva MA; Molteni R
    Expert Opin Ther Targets; 2016 Oct; 20(10):1195-207. PubMed ID: 27167520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of sex steroid hormones and brain-derived neurotrophic factor-tyrosine kinase B signalling: relevance to schizophrenia and depression.
    Hill RA
    J Neuroendocrinol; 2012 Dec; 24(12):1553-61. PubMed ID: 22845879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and cellular actions of chronic electroconvulsive seizures.
    Duman RS; Vaidya VA
    J ECT; 1998 Sep; 14(3):181-93. PubMed ID: 9773357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame?
    Eastwood SL
    Int Rev Neurobiol; 2004; 59():47-72. PubMed ID: 15006484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients.
    Takahashi M; Shirakawa O; Toyooka K; Kitamura N; Hashimoto T; Maeda K; Koizumi S; Wakabayashi K; Takahashi H; Someya T; Nawa H
    Mol Psychiatry; 2000 May; 5(3):293-300. PubMed ID: 10889532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning.
    Tyler WJ; Alonso M; Bramham CR; Pozzo-Miller LD
    Learn Mem; 2002; 9(5):224-37. PubMed ID: 12359832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions.
    Begni V; Riva MA; Cattaneo A
    Clin Sci (Lond); 2017 Jan; 131(2):123-138. PubMed ID: 28011898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation of the BDNF gene and its relevance to psychiatric disorders.
    Ikegame T; Bundo M; Murata Y; Kasai K; Kato T; Iwamoto K
    J Hum Genet; 2013 Jul; 58(7):434-8. PubMed ID: 23739121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.
    Notaras M; Hill R; van den Buuse M
    Neurosci Biobehav Rev; 2015 Apr; 51():15-30. PubMed ID: 25562189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls.
    Shimizu E; Hashimoto K; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Nakazato M; Kumakiri C; Okada S; Iyo M
    Neurosci Lett; 2003 Nov; 351(2):111-4. PubMed ID: 14583394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune involvement in schizophrenia and autism: etiology, pathology and animal models.
    Patterson PH
    Behav Brain Res; 2009 Dec; 204(2):313-21. PubMed ID: 19136031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?
    Waddington JL; Lane A; Scully PJ; Larkin C; O'Callaghan E
    Psychiatr Clin North Am; 1998 Mar; 21(1):123-49. PubMed ID: 9551494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.